Previous studies showed that compared to adjacent normal tissues, MEG3 is downregulated in a number of cancers such as breast cancer (J.J. [38]), glioma cells [16], colorectal cancer [39], and cervical cancer (R. [40]). This evidence concerns the gene MEG3 and colorectal cancer.